VRE resistance mechanisms US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for VRE resistance mechanisms. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
VRE resistance mechanisms US Medical PG Question 1: A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?
- A. Intrinsic absence of a target site for the drug
- B. Use of an altered metabolic pathway
- C. Production of beta-lactamase enzyme (Correct Answer)
- D. Altered structural target for the drug
- E. Drug efflux pump
VRE resistance mechanisms Explanation: ***Production of beta-lactamase enzyme***
- The patient's symptoms of a rapidly worsening infection despite ampicillin treatment suggest the presence of a **beta-lactamase producing organism**. Ampicillin is a **beta-lactam antibiotic** that is inactivated by these enzymes.
- Anorectal abscesses and rapidly progressing soft tissue infections are often caused by **polymicrobial flora**, including staphylococci and enterococci, many of which can produce **beta-lactamase**.
*Intrinsic absence of a target site for the drug*
- While some bacteria inherently lack the target site for certain drugs (e.g., mycoplasma lacking a cell wall, thus being resistant to beta-lactams), this is less likely to be the **most common mechanism of acquired resistance** leading to treatment failure in a typical perianal infection.
- The rapid progression and failed initial treatment point towards an **acquired mechanism of resistance** rather than an intrinsic one.
*Use of an altered metabolic pathway*
- This mechanism, such as altered **folate synthesis pathways** in resistance to trimethoprim-sulfamethoxazole, is less common as the primary mechanism for ampicillin resistance.
- Ampicillin's mechanism of action primarily targets the **bacterial cell wall**, not a metabolic pathway in the same way.
*Altered structural target for the drug*
- This involves modifications to the **penicillin-binding proteins (PBPs)**, which are the targets of beta-lactam antibiotics like ampicillin. While a valid mechanism (e.g., in MRSA), the **production of beta-lactamase** is generally a more widespread and common cause of ampicillin failure, especially in infections involving mixed flora from the perianal region.
- Given the abrupt failure of ampicillin, **beta-lactamase inactivation** is a more immediate and common cause than a rapid mutational change in PBPs.
*Drug efflux pump*
- **Efflux pumps** actively remove antibiotics from the bacterial cell, contributing to resistance against various drug classes.
- While efflux pumps can play a role, the dominant mechanism for resistance to **ampicillin** in many common perianal pathogens is the **enzymatic degradation by beta-lactamases**.
VRE resistance mechanisms US Medical PG Question 2: A 31-year-old female with a bacterial infection is prescribed a drug that binds the dipeptide D-Ala-D-Ala. Which of the following drugs was this patient prescribed?
- A. Polymyxin B
- B. Nalidixic acid
- C. Chloramphenicol
- D. Vancomycin (Correct Answer)
- E. Penicillin
VRE resistance mechanisms Explanation: ***Vancomycin***
- **Vancomycin** is a glycopeptide antibiotic that directly binds to the **D-Ala-D-Ala** terminus of peptidoglycan precursors.
- This binding prevents the **transpeptidation** and **transglycosylation** steps required for bacterial cell wall synthesis, leading to cell lysis.
*Polymyxin B*
- **Polymyxins** are **cationic detergents** that disrupt the integrity of the bacterial **outer membrane** in Gram-negative bacteria.
- They bind to **lipopolysaccharide (LPS)**, causing increased permeability and leakage of intracellular components, but do not target D-Ala-D-Ala.
*Nalidixic acid*
- **Nalidixic acid** is a **quinolone antibiotic** that inhibits bacterial **DNA gyrase (topoisomerase II)** and **topoisomerase IV**.
- Its mechanism of action involves preventing DNA replication and transcription, not cell wall synthesis or D-Ala-D-Ala binding.
*Chloramphenicol*
- **Chloramphenicol** is an antibiotic that inhibits bacterial **protein synthesis** by binding to the **50S ribosomal subunit**.
- It prevents the formation of **peptide bonds** by inhibiting peptidyl transferase, an entirely different target from D-Ala-D-Ala in the cell wall.
*Penicillin*
- **Penicillin** is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to and inactivating **penicillin-binding proteins (PBPs)**.
- PBPs are **transpeptidases** involved in cross-linking peptidoglycan, but penicillin does not directly bind to the D-Ala-D-Ala substrate itself; instead, it prevents the enzymes from using it.
VRE resistance mechanisms US Medical PG Question 3: A 42-year-old man presents with an intermittent low-to-high grade fever, night sweats, weight loss, fatigue, and exercise intolerance. The symptoms have been present for the last 6 months. The patient is a software developer. He smokes one-half pack of cigarettes daily and drinks alcohol occasionally. He denies intravenous drug use. There is no history of cardiovascular, respiratory, or gastrointestinal diseases or malignancies. There is no family history of cancer or cardiovascular diseases. The only condition he reports is a urinary bladder polyp, which was diagnosed and removed endoscopically almost 8 months ago. The patient does not currently take any medications. His blood pressure is 100/80 mm Hg, heart rate is 107/min, respiratory rate is 19/min, and temperature is 38.1°C (100.6°F). The patient is ill-looking and pale. There are several petechial conjunctival hemorrhages and macular lesions on both palms. The cardiac examination reveals heart enlargement to the left side and a holosystolic murmur best heard at the apex of the heart. There is also symmetric edema in both legs up to the knees. Which of the following organisms is most likely to be cultured from the patient’s blood?
- A. Pseudomonas aeruginosa
- B. Candida albicans
- C. Streptococcus viridans (Correct Answer)
- D. Staphylococcus aureus
- E. Enterococcus faecalis
VRE resistance mechanisms Explanation: ***Streptococcus viridans***
- The patient's symptoms (fever, night sweats, weight loss, fatigue, new-onset **holosystolic murmur**, **petechial hemorrhages**, **macular lesions on palms**) are highly suggestive of **subacute infective endocarditis**.
- **Viridans streptococci** are the most common cause of **subacute bacterial endocarditis** overall, accounting for 50-60% of cases on previously damaged heart valves or in individuals with predisposing conditions.
- While the patient had a bladder polyp removed **8 months ago**, the remote timing (well beyond typical endocarditis prophylaxis windows) and the **6-month duration of symptoms** make viridans the most likely pathogen statistically.
*Pseudomonas aeruginosa*
- This organism primarily causes endocarditis in **intravenous drug users** or in patients with **prosthetic valves**, which are not present in this case.
- The patient denies IVDU, making this organism less likely.
*Candida albicans*
- **Fungal endocarditis** due to *Candida* is rare and typically occurs in immunocompromised individuals, those with prosthetic valves, or long-term central venous catheter users.
- There is no indication of immunocompromise or prosthetic valves in this patient.
*Staphylococcus aureus*
- **Staphylococcus aureus** causes **acute infective endocarditis**, often presenting with rapid onset and severe symptoms over days to weeks, frequently involving healthy valves and **intravenous drug users**.
- The patient's **6-month history** of symptoms points to a subacute, rather than an acute, process, making S. aureus less likely.
*Enterococcus faecalis*
- **Enterococcus faecalis** is indeed associated with endocarditis following **genitourinary procedures** (including cystoscopy with polypectomy).
- However, the **8-month interval** between the GU procedure and symptom onset is quite remote; most procedure-related endocarditis develops within weeks to a few months.
- Additionally, while enterococcus causes 5-15% of endocarditis cases, **viridans streptococci remain the most common cause of subacute endocarditis overall**, making it the statistically more likely pathogen in this clinical presentation.
VRE resistance mechanisms US Medical PG Question 4: A researcher is studying a new antituberculosis drug. In the laboratory, the drug has been shown to be effective against mycobacteria located within phagolysosomes of macrophages, but it is also significantly less effective against extracellular tuberculoid bacteria. The characteristics of this drug are most similar to which of the following agents?
- A. Isoniazid
- B. Pyrazinamide (Correct Answer)
- C. Ethambutol
- D. Streptomycin
- E. Rifampin
VRE resistance mechanisms Explanation: ***Pyrazinamide***
- Pyrazinamide is unique among antituberculosis drugs for its efficacy in the **acidic environment of phagolysosomes**, where dormant mycobacteria reside.
- It is **less effective against actively replicating extracellular bacteria** at neutral pH, aligning with the drug's described characteristics.
*Isoniazid*
- Isoniazid is primarily effective against **rapidly dividing, extracellular *M. tuberculosis*** by inhibiting mycolic acid synthesis.
- While it can penetrate macrophages, its activity is not specifically enhanced or limited by the acidic phagolysosomal environment as described.
*Ethambutol*
- Ethambutol primarily inhibits **arabinogalactan synthesis**, affecting the cell wall of growing mycobacteria, both intracellular and extracellular.
- Its efficacy is not selectively focused on the acidic intracellular environment.
*Streptomycin*
- Streptomycin is an **aminoglycoside antibiotic** that inhibits protein synthesis and is active against extracellular mycobacteria.
- It has limited penetration into cells and is not particularly effective against intracellular organisms, nor is its activity pH-dependent.
*Rifampin*
- Rifampin is highly effective against both **extracellular and intracellular mycobacteria** by inhibiting DNA-dependent RNA polymerase.
- It exhibits strong sterilizing activity across various environments, which contradicts the described drug's selective efficacy.
VRE resistance mechanisms US Medical PG Question 5: You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?
- A. It binds the 50S ribosomal subunit and inhibits formation of the initiation complex
- B. It binds the 30S ribosomal subunit and inhibits formation of the initiation complex (Correct Answer)
- C. It binds the 30S ribosomal subunit and reversibly inhibits translocation
- D. It binds the 50S ribosomal subunit and inhibits peptidyltransferase
- E. It binds the 50S ribosomal subunit and reversibly inhibits translocation
VRE resistance mechanisms Explanation: ***It binds the 30s ribosomal subunit and inhibits formation of the initiation complex***
- The second antibiotic, X, is likely an **aminoglycoside**, such as **gentamicin** or **amikacin**, which are commonly used in combination with ampicillin for neonatal meningitis and are known to cause ototoxicity.
- Aminoglycosides exert their bactericidal effect by **irreversibly binding to the 30S ribosomal subunit**, thereby **inhibiting the formation of the initiation complex** and leading to misreading of mRNA.
*It binds the 50S ribosomal subunit and inhibits formation of the initiation complex*
- This mechanism is characteristic of **linezolid**, which targets the 50S ribosomal subunit to prevent the formation of the initiation complex.
- While linezolid can cause side effects, **ototoxicity** is less commonly associated with it compared to aminoglycosides, and it is not a primary drug for neonatal meningitis alongside ampicillin.
*It binds the 50S ribosomal subunit and inhibits peptidyltransferase*
- This is the mechanism of action for **chloramphenicol**, which inhibits **peptidyltransferase** activity on the 50S ribosomal subunit, preventing peptide bond formation.
- Although chloramphenicol can cause **ototoxicity** and **aplastic anemia**, its use in neonates is limited due to the risk of **Gray Baby Syndrome**.
*It binds the 30s ribosomal subunit and reversibly inhibits translocation*
- This describes the mechanism of action of **tetracyclines**, which reversibly bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA, thereby inhibiting protein synthesis.
- Tetracyclines are **contraindicated in neonates** due to their potential to cause **tooth discoloration** and **bone growth inhibition**, and ototoxicity is not their primary adverse effect.
*It binds the 50s ribosomal subunit and reversibly inhibits translocation*
- This mechanism of reversibly inhibiting translocation by binding to the 50S ribosomal subunit is characteristic of **macrolides** (e.g., erythromycin, azithromycin) and **clindamycin**.
- While some macrolides can cause **transient ototoxicity**, they are not typically the second antibiotic of choice for neonatal meningitis in combination with ampicillin, and clindamycin's side effect profile is different.
VRE resistance mechanisms US Medical PG Question 6: An investigator studying mechanisms of acquired antibiotic resistance in bacteria conducts a study using isolated strains of Escherichia coli and Staphylococcus aureus. The E. coli strain harbors plasmid pRK212.1, which conveys resistance to kanamycin. The S. aureus strain is susceptible to kanamycin. Both bacterial strains are mixed in a liquid growth medium containing deoxyribonuclease. After incubation for 2 days and subsequent transfer to a solid medium, the S. aureus colonies show no lysis in response to the application of kanamycin. Analysis of chromosomal DNA from the kanamycin-resistant S. aureus strain does not reveal the kanamycin-resistance gene. Which of the following mechanisms is most likely responsible for this finding?
- A. Transformation
- B. Conjugation (Correct Answer)
- C. Transduction
- D. Transposition
- E. Secretion
VRE resistance mechanisms Explanation: ***Conjugation***
- The presence of **deoxyribonuclease (DNase)** in the growth medium inhibits **transformation**, ruling out the uptake of naked DNA. The transfer of the kanamycin resistance gene from a plasmid in *E. coli* to *S. aureus* in the presence of DNase strongly points to **cell-to-cell contact** via conjugation.
- The resistance gene is found on a **plasmid** in *E. coli* and is transferred to *S. aureus*, resulting in kanamycin resistance without integrating into the *S. aureus* chromosome, which is characteristic of conjugative plasmid transfer.
- **Key experimental clue**: DNase destroys free DNA in the medium, so the only way for genetic material to transfer is through **direct cell-to-cell contact**, which is the hallmark of conjugation.
*Transformation*
- This process involves the uptake of **naked DNA** from the environment by a bacterial cell, which would have been prevented by the presence of **deoxyribonuclease** in the medium.
- Transformation typically results in the integration of the foreign DNA into the host cell's **chromosome** or stable maintenance as a plasmid, but DNase would degrade any free DNA before uptake could occur.
*Transduction*
- **Transduction** involves the transfer of genetic material via a **bacteriophage**. The scenario does not describe the presence of any phage particles, nor is there mention of viral vectors.
- The resistance gene originates from a **plasmid** in *E. coli*, and transduction would require a phage capable of infecting both species, which is not mentioned in the experimental design.
*Transposition*
- **Transposition** is the movement of a segment of DNA from one location to another within the **same cell** (e.g., between a plasmid and chromosome). It does not explain the transfer of genetic material **between** two different bacterial cells.
- While a **transposon** might carry the kanamycin resistance gene on the plasmid, transposition itself is not the mechanism for **inter-species transfer** observed in this experiment.
*Secretion*
- **Secretion** refers to the active release of molecules (proteins, enzymes, toxins) from a cell. It is not a mechanism for the direct transfer of **genetic material** (like a plasmid or gene) from one bacterium to another.
- Genetic material is transferred through conjugation, transformation, or transduction, not by secretion pathways.
VRE resistance mechanisms US Medical PG Question 7: A 64-year-old female with type 2 diabetes mellitus comes to the physician because of a 1-week history of painful red swelling on her left thigh. Examination shows a 3- x 4-cm, tender, fluctuant mass. Incision and drainage of the abscess are performed. Culture of the abscess fluid grows gram-positive, coagulase-positive cocci that are resistant to oxacillin. Which of the following best describes the mechanism of resistance of the causal organism to oxacillin?
- A. Degradation of the antibiotic
- B. Decreased uptake of the antibiotic
- C. Decreased activation of the antibiotic
- D. Altered target of the antibiotic (Correct Answer)
- E. Acetylation of the antibiotic
VRE resistance mechanisms Explanation: ***Altered target of the antibiotic***
- The organism described (gram-positive, coagulase-positive cocci, oxacillin-resistant) is **methicillin-resistant *Staphylococcus aureus* (MRSA)**.
- MRSA achieves oxacillin (and other beta-lactam) resistance by acquiring the ***mecA* gene**, which encodes for a **modified penicillin-binding protein (PBP2a)** with reduced affinity for beta-lactam antibiotics.
*Degradation of the antibiotic*
- This mechanism, primarily through the production of **beta-lactamase enzymes**, can degrade beta-lactam antibiotics.
- While *Staphylococcus aureus* can produce beta-lactamases, oxacillin (a **penicillinase-resistant penicillin**) is specifically engineered to be stable against these enzymes.
*Decreased uptake of the antibiotic*
- Reduced permeability of the bacterial cell wall can lead to decreased uptake, a mechanism more commonly associated with **gram-negative bacteria** due to their outer membrane.
- This is not the primary mechanism of resistance for MRSA to oxacillin.
*Decreased activation of the antibiotic*
- Some antibiotics are prodrugs that require activation by bacterial enzymes, and resistance can arise from mutations affecting this activation.
- Oxacillin is active in its administered form and does not require bacterial activation.
*Acetylation of the antibiotic*
- **Enzymatic modification**, such as acetylation, adenylylation, or phosphorylation, is a common mechanism of resistance, particularly against **aminoglycoside antibiotics**.
- This specific mechanism is not responsible for oxacillin resistance in MRSA.
VRE resistance mechanisms US Medical PG Question 8: A medical student is performing research on the properties of viruses in order to determine the transmission patterns of various organisms. He accidentally drops a rack of tubes and spills various virus samples on the benchtop. Upon seeing this, the laboratory technician wipes down the workbench with alcohol in order to clean up the spill. Which of the following organisms would most likely still be alive after this cleaning?
- A. Coronavirus and herpesvirus
- B. Adenovirus and coronavirus
- C. Coronavirus and rhinovirus
- D. Adenovirus and rhinovirus (Correct Answer)
- E. Adenovirus and herpesvirus
VRE resistance mechanisms Explanation: ***Adenovirus and rhinovirus***
- **Adenovirus** and **rhinovirus** are both **non-enveloped viruses**, meaning they lack a lipid envelope.
- Non-enveloped viruses are generally **more resistant** to inactivation by alcohol-based disinfectants because alcohol primarily acts by dissolving lipid envelopes.
*Coronavirus and herpesvirus*
- Both **coronavirus** and **herpesvirus** are **enveloped viruses**.
- **Enveloped viruses** are highly susceptible to destruction by alcohol, which disrupts their lipid envelope.
*Adenovirus and coronavirus*
- While **adenovirus** is non-enveloped and resistant, **coronavirus** is enveloped and thus susceptible to alcohol.
- Therefore, the coronavirus component of this pair would likely be inactivated.
*Coronavirus and rhinovirus*
- While **rhinovirus** is non-enveloped and resistant, **coronavirus** is enveloped and thus susceptible to alcohol.
- As a result, the coronavirus would likely be destroyed by the alcohol.
*Adenovirus and herpesvirus*
- While **adenovirus** is non-enveloped and resistant, **herpesvirus** is enveloped and susceptible to alcohol.
- The herpesvirus would likely be inactivated by the alcohol cleaning.
VRE resistance mechanisms US Medical PG Question 9: A 24-year old G1P0 mother with no prenatal screening arrives to the hospital in labor and has an uneventful delivery. The infant is full term and has no significant findings on physical exam. Shortly after birth, an erythromycin ophthalmic ointment is applied to the newborn in order to provide prophylaxis against infection. Which of the following is the most common mechanism of resistance to the ointment applied to this newborn?
- A. Methylation of 23S rRNA-binding site (Correct Answer)
- B. Alteration of cell wall peptidoglycan
- C. Increased efflux out of bacterial cells with plasmid-encoded transport pumps
- D. Mutation in DNA polymerase
- E. Penicillinase in bacteria cleaves the beta-lactam ring
VRE resistance mechanisms Explanation: ***Methylation of 23S rRNA-binding site***
- Erythromycin is a **macrolide antibiotic** that inhibits bacterial protein synthesis by binding to the **23S ribosomal RNA** component of the 50S ribosomal subunit.
- The most common mechanism of resistance to erythromycin in *Neisseria gonorrhoeae* (the primary target for prophylaxis) involves methylation of this binding site, which **prevents erythromycin from effectively binding** and exerts its action.
*Alteration of amino acid cell wall*
- This mechanism is not typical for resistance to erythromycin or other macrolides, as their primary target is **bacterial ribosomes**, not the cell wall.
- Alterations in the cell wall are more commonly associated with resistance to antibiotics like **beta-lactams** (e.g., penicillin) that target cell wall synthesis.
*Increased efflux out of bacterial cells with plasmid-encoded transport pumps*
- While efflux pumps are a known resistance mechanism for various antibiotics, including macrolides, they are **not the most common or primary mechanism** for erythromycin resistance in *Neisseria gonorrhoeae*.
- **MefA** and **mrsA** efflux pumps can lead to macrolide resistance, but ribosomal modification is more prevalent.
*Mutation in DNA polymerase*
- Mutations in **DNA polymerase** would typically affect DNA replication and repair, leading to resistance to antibiotics that target these processes, such as **fluoroquinolones**.
- Erythromycin does not inhibit DNA polymerase; its mechanism of action is on **protein synthesis**.
*Penicillinase in bacteria cleaves the beta-lactam ring*
- **Penicillinase** is an enzyme that specifically **cleaves the beta-lactam ring** of penicillin and other beta-lactam antibiotics, rendering them inactive.
- Erythromycin is a **macrolide**, not a beta-lactam antibiotic, and is therefore not affected by penicillinase.
VRE resistance mechanisms US Medical PG Question 10: A 32-year-old man is brought to the emergency department with fever, dyspnea, and impaired consciousness. His wife reports that he has also had an episode of dark urine today. Two weeks ago, he returned from a trip to the Republic of Congo. His temperature is 39.4°C (103°F), pulse is 114/min, and blood pressure is 82/51 mm Hg. Physical examination shows scleral icterus. Decreased breath sounds and expiratory crackles are heard on auscultation of the lungs bilaterally. His hemoglobin concentration is 6.3 g/dL. A blood smear shows red blood cells with normal morphology and ring-shaped inclusions. Further laboratory testing shows normal rates of NADPH production. Which of the following is the most appropriate pharmacotherapy for this patient?
- A. Proguanil
- B. Dapsone
- C. Chloroquine
- D. Artesunate (Correct Answer)
- E. Atovaquone
VRE resistance mechanisms Explanation: ***Artesunate***
- This patient presents with **severe malaria**, indicated by fever, impaired consciousness, hypotension, dyspnea, dark urine (hemoglobinuria), scleral icterus (hemolysis), and anemia, following travel to an endemic area (Republic of Congo). The blood smear finding of **ring-shaped inclusions** with normal red cell morphology is characteristic of **Plasmodium falciparum** infection.
- **Artesunate** is the drug of choice for **severe malaria** due to its rapid parasitic clearance and superior efficacy compared to other antimalarials, especially in regions with high chloroquine resistance, as is typical in the Republic of Congo for *P. falciparum*.
*Proguanil*
- Proguanil is primarily used in **malaria prophylaxis** or in combination with other drugs (e.g., atovaquone-proguanil) for uncomplicated malaria.
- It is not indicated as monotherapy for **severe *P. falciparum* malaria**, nor is it suitable for emergency treatment of life-threatening infections.
*Dapsone*
- Dapsone is an **antibiotic** primarily used in the treatment of **leprosy** and prevention of *Pneumocystis jirovecii* pneumonia or toxoplasmosis in immunocompromised patients.
- It has **no significant role** in the treatment of malaria, especially severe *P. falciparum* infection.
*Chloroquine*
- Chloroquine was historically a first-line treatment for malaria but is largely ineffective against **chloroquine-resistant *P. falciparum***, which is widely prevalent in the Republic of Congo and contributes to severe disease.
- Administering chloroquine in this context would likely lead to **treatment failure** and worsening of the patient's severe condition.
*Atovaquone*
- Atovaquone, usually combined with proguanil (Malarone), is effective for **uncomplicated malaria** and prophylaxis.
- However, it is **not the preferred agent for severe malaria** due to slower action and lack of intravenous formulation for initial critical management.
More VRE resistance mechanisms US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
